CARDIO- ONCOLOGY

Team and subespecialty Car diovascular (CV) disease and cancer have high mor tality r ates
r equir es

Epidemiology Factors for CV risk Car diotoxicity may compr omise Diagnostic tools
Colabor ative wor ks the ef f ectiveness
of the anticancer ther apy

Car diotoxity iit's a ECG

common cause of Pr evious car diotoxic Lif e-style r isk Complications
f actor s Resting tachycar dia,
Expir enced staf f mor bidity and mor tality in cancer tr eatment ST-T changes,
cancer sur vivor s conduction
distur bances and
Myocar dial dysf untion QT inter val
High alcohol pr olongation
intake obesity,
Appr opr iate location: CV pr oblems in cancer Cur r ent myocar dial sedentar y
in close pr oximity to patients have social and disease lif estyle and
smoking Hear t f ailur e
those specialities that economic implications.
r ef er lar ge number s Biomar ker
of patients assessment
- Hear t f ailur e
inclouding LVF Thr omboembolic disease
Invasive cancer is mor e - Evidence of Demogr aphic
common in men cor onar y ar ter y r isk f actor s
disease Nuclear car diac
CV testing - Valvular hear t Per ipher al vascular imaging MRI
disease disease and str oke
The pr ogr ess in the - Ar ter ial -Aage
tr eatment of malignant hyper tension with - Family histor y
diseases signif icantly impair ed LVF of pr ematur e
impr oved sur vival of - Hyper tr ophic, CV disease Per icar dial complications Echocar diogr aphy
Car dio-oncology nur se oncological patients dilated or r estr ictive - Ar ter ial (2D or 3D)
coor dinator is needed car diomyopathy hyper tension
- Car diac - DM
sar coidosis; and - Hyper choles- Cor onar y ar ter y disease
ar r hythmias ter olemia and valvular disease
The impr oved sur vival of
oncological patients can
be limited by adver se
ef f ects associated with Pulmonar y and ar ter ial
intensive antitumor ous hyper tension
tr eatment.

Ar r hytmias: especially those

induced by QT-pr olonging dr ugs
HERNÁNDEZ FRANCO BERENICE